The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; MSD; Roche; Takeda
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; MSD; Roche
Research Funding - AstraZeneca; Bristol-Myers Squibb; Roche
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Roche

Checkmate 77T: A phase III trial of neoadjuvant nivolumab (NIVO) plus chemotherapy (chemo) followed by adjuvant nivo in resectable early-stage NSCLC.
 
Tina Cascone
Honoraria - Bristol-Myers Squibb; Society for Immunotherapy of Cancer; Society for Immunotherapy of Cancer
Consulting or Advisory Role - MedImmune
Research Funding - Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); MedImmune (Inst)
 
Mariano Provencio
No Relationships to Disclose
 
Boris Sepesi
No Relationships to Disclose
 
Shun Lu
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Hutchison MediPharma; Roche; Simcere
Speakers' Bureau - AstraZeneca; Hansoh; Roche
Research Funding - AstraZeneca; Bristol-Myers Squibb; HenRui; Hutchison MediPharma; Roche
 
Nivedita Aanur
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Sunney Li
Employment - Bristol-Myers Squibb; Lilly
Stock and Other Ownership Interests - Bristol-Myers Squibb; Lilly
 
Jonathan Spicer
Honoraria - AstraZeneca; Bristol-Myers Squibb; Trans-Hit Biomarker
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Trans-Hit Biomarker
Travel, Accommodations, Expenses - AstraZeneca